New osteoporosis drug matches prolia in bone strength study
NCT ID NCT05345691
First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 30 times
Summary
This study tested whether a new drug called Bmab 1000 works as well as the approved drug Prolia for treating osteoporosis in women after menopause. About 479 women with weak bones took part. The main goal was to see if Bmab 1000 could improve bone density as much as Prolia after one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
PPD Global Ltd, Granta Park, Great Abington,
Cambridge, UK, CB21 6GQ, United Kingdom
Conditions
Explore the condition pages connected to this study.